Novartis experimental prostate cancer drug gets FDA breakthrough designation
https://healthell.blogspot.com/2021/06/novartis-experimental-prostate-cancer.html
Novartis experimental prostate cancer drug gets FDA breakthrough designation
Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.
